View Future GrowthBaikowski 과거 순이익 실적과거 기준 점검 1/6Baikowski의 수입은 연평균 -6.6%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 4.4% 감소했습니다. 매출은 연평균 2.4%의 비율로 증가해 왔습니다. Baikowski의 자기자본이익률은 8.1%이고 순이익률은 7.4%입니다.핵심 정보-6.58%순이익 성장률-6.64%주당순이익(EPS) 성장률Chemicals 산업 성장률12.41%매출 성장률2.37%자기자본이익률8.11%순이익률7.41%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트공시 • Jul 25Baikowski SA to Report First Half, 2025 Results on Sep 29, 2025Baikowski SA announced that they will report first half, 2025 results on Sep 29, 2025Reported Earnings • Sep 25First half 2024 earnings released: EPS: €0.59 (vs €0.66 in 1H 2023)First half 2024 results: EPS: €0.59 (down from €0.66 in 1H 2023). Revenue: €26.0m (up 13% from 1H 2023). Net income: €2.17m (down 11% from 1H 2023). Profit margin: 8.3% (down from 11% in 1H 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Reported Earnings • Apr 06Full year 2023 earnings released: EPS: €0.25 (vs €1.78 in FY 2022)Full year 2023 results: EPS: €0.25 (down from €1.78 in FY 2022). Revenue: €36.0m (down 32% from FY 2022). Net income: €938.0k (down 86% from FY 2022). Profit margin: 2.6% (down from 12% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 3% per year.공시 • Jan 30+ 2 more updatesBaikowski SA to Report Fiscal Year 2023 Final Results on Apr 05, 2024Baikowski SA announced that they will report fiscal year 2023 final results at 8:45 AM, Central European Standard Time on Apr 05, 2024Reported Earnings • Oct 11First half 2023 earnings released: EPS: €0.66 (vs €1.05 in 1H 2022)First half 2023 results: EPS: €0.66 (down from €1.05 in 1H 2022). Revenue: €22.9m (down 18% from 1H 2022). Net income: €2.44m (down 37% from 1H 2022). Profit margin: 11% (down from 14% in 1H 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Reported Earnings • Apr 21Full year 2022 earnings released: EPS: €1.78 (vs €1.85 in FY 2021)Full year 2022 results: EPS: €1.78 (down from €1.85 in FY 2021). Revenue: €53.0m (up 18% from FY 2021). Net income: €6.54m (down 3.5% from FY 2021). Profit margin: 12% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.모든 업데이트 보기Recent updatesBoard Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Claude Djololian was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • May 02Baikowski SA announces Annual dividend, payable on June 30, 2026Baikowski SA announced Annual dividend of EUR 0.3000 per share payable on June 30, 2026, ex-date on June 26, 2026 and record date on June 29, 2026.공시 • Apr 11Baikowski SA, Annual General Meeting, Jun 11, 2026Baikowski SA, Annual General Meeting, Jun 11, 2026.공시 • Jan 23Baikowski SA Announces Chief Executive Officer ChangesBaikowski announced a change in its executive management with the resignation of CEO Benoît Grenot, effective January 30, 2026. After more than ten years at the helm of the Group’s executive management, Benoît Grenot has decided to pursue a new professional project. The Board of Directors, chaired by François-Xavier Entremont, acknowledged Grenot's resignation. In the meantime, François-Xavier Entremont, Chairman of the Board of Directors, will assume the role of Chief Executive Officer on an interim basis and will ensure the continued implementation of the Group's development strategy.공시 • Jul 25Baikowski SA to Report First Half, 2025 Results on Sep 29, 2025Baikowski SA announced that they will report first half, 2025 results on Sep 29, 2025공시 • May 13Baikowski SA, Annual General Meeting, Jun 16, 2025Baikowski SA, Annual General Meeting, Jun 16, 2025. Location: 1046 route de chaumontet, poisy FranceReported Earnings • Sep 25First half 2024 earnings released: EPS: €0.59 (vs €0.66 in 1H 2023)First half 2024 results: EPS: €0.59 (down from €0.66 in 1H 2023). Revenue: €26.0m (up 13% from 1H 2023). Net income: €2.17m (down 11% from 1H 2023). Profit margin: 8.3% (down from 11% in 1H 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jul 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €15.00, the stock trades at a trailing P/E ratio of 61.4x. Average trailing P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 12% over the past three years.New Risk • Apr 06New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.6% Last year net profit margin: 12% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.6% net profit margin). Market cap is less than US$100m (€49.2m market cap, or US$53.3m).Reported Earnings • Apr 06Full year 2023 earnings released: EPS: €0.25 (vs €1.78 in FY 2022)Full year 2023 results: EPS: €0.25 (down from €1.78 in FY 2022). Revenue: €36.0m (down 32% from FY 2022). Net income: €938.0k (down 86% from FY 2022). Profit margin: 2.6% (down from 12% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 3% per year.공시 • Jan 30+ 2 more updatesBaikowski SA to Report Fiscal Year 2023 Final Results on Apr 05, 2024Baikowski SA announced that they will report fiscal year 2023 final results at 8:45 AM, Central European Standard Time on Apr 05, 2024Reported Earnings • Oct 11First half 2023 earnings released: EPS: €0.66 (vs €1.05 in 1H 2022)First half 2023 results: EPS: €0.66 (down from €1.05 in 1H 2022). Revenue: €22.9m (down 18% from 1H 2022). Net income: €2.44m (down 37% from 1H 2022). Profit margin: 11% (down from 14% in 1H 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Jun 21Upcoming dividend of €0.60 per share at 3.4% yieldEligible shareholders must have bought the stock before 28 June 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (6.1%).Reported Earnings • Apr 21Full year 2022 earnings released: EPS: €1.78 (vs €1.85 in FY 2021)Full year 2022 results: EPS: €1.78 (down from €1.85 in FY 2021). Revenue: €53.0m (up 18% from FY 2021). Net income: €6.54m (down 3.5% from FY 2021). Profit margin: 12% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Claude Djololian was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improved over the past weekAfter last week's 17% share price gain to €29.60, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 9x in the Chemicals industry in Germany. Total returns to shareholders of 98% over the past three years.Reported Earnings • Apr 27Full year 2021 earnings released: EPS: €1.85 (vs €0.35 in FY 2020)Full year 2021 results: EPS: €1.85 (up from €0.35 in FY 2020). Revenue: €44.9m (up 26% from FY 2020). Net income: €6.78m (up 429% from FY 2020). Profit margin: 15% (up from 3.6% in FY 2020). The increase in margin was driven by higher revenue.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Claude Djololian was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Jan 30+ 1 more updateBaikowski SA to Report First Half, 2022 Results on Sep 28, 2022Baikowski SA announced that they will report first half, 2022 results on Sep 28, 2022공시 • Jan 28Baikowski SA, Annual General Meeting, May 20, 2022Baikowski SA, Annual General Meeting, May 20, 2022.Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 18% share price gain to €21.40, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 102% over the past year.Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improved over the past weekAfter last week's 51% share price gain to €20.80, the stock trades at a trailing P/E ratio of 14.6x. Average trailing P/E is 19x in the Chemicals industry in Germany. Total returns to shareholders of 120% over the past year.Reported Earnings • Oct 03First half 2021 earnings released: EPS €0.89 (vs €0.11 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €21.7m (up 33% from 1H 2020). Net income: €3.27m (up €3.68m from 1H 2020). Profit margin: 15% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue.Is New 90 Day High Low • Jan 19New 90-day high: €12.10The company is up 35% from its price of €8.95 on 21 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to €12.10, the stock is trading at a trailing P/E ratio of 27.9x, up from the previous P/E ratio of 23x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total return to shareholders over the past year is a loss of 8.0%.공시 • Jan 15+ 2 more updatesBaikowski Société anonyme to Report First Half, 2021 Results on Sep 29, 2021Baikowski Société anonyme announced that they will report first half, 2021 results on Sep 29, 2021Valuation Update With 7 Day Price Move • Dec 23Investor sentiment improved over the past weekAfter last week's 16% share price gain to €10.70, the stock is trading at a trailing P/E ratio of 27.9x, up from the previous P/E ratio of 24x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total return to shareholders over the past year is a loss of 19%.Is New 90 Day High Low • Dec 22New 90-day high: €10.50The company is up 9.0% from its price of €9.65 on 23 September 2020. The German market is also up 9.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 20% over the same period.Is New 90 Day High Low • Nov 05New 90-day low: €8.10The company is down 15% from its price of €9.50 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period.Is New 90 Day High Low • Oct 21New 90-day low: €8.95The company is down 7.0% from its price of €9.65 on 23 July 2020. The German market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period.Reported Earnings • Oct 01First half earnings releasedOver the last 12 months the company has reported total profits of €1.59m, down 17% from the prior year. Total revenue was €38.8m over the last 12 months, largely unchanged from the prior year.매출 및 비용 세부 내역Baikowski가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:3BK 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 2551427330 Sep 2550527330 Jun 2548627331 Mar 2548527331 Dec 2448426330 Sep 2443225330 Jun 2439124331 Mar 2437124331 Dec 2336124330 Sep 2342325330 Jun 2348526331 Mar 2350628331 Dec 2253729330 Sep 2252728330 Jun 2251728331 Mar 2248727331 Dec 2145726330 Sep 2143625330 Jun 2141525331 Mar 2138324231 Dec 2036123230 Sep 2037123230 Jun 2039224231 Mar 2040225231 Dec 1940326230 Sep 1940226230 Jun 1939226231 Mar 1940326231 Dec 1842426330 Sep 1842524330 Jun 1842623231 Mar 1841523231 Dec 1740423231 Dec 16414252양질의 수익: 3BK는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 3BK의 현재 순 이익률 (7.4%)은 지난해 (7.9%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 3BK의 수익은 지난 5년 동안 연평균 6.6% 감소했습니다.성장 가속화: 3BK은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: 3BK은 지난 1년 동안 수익이 감소(-1%)하여 Chemicals 업계 평균(-13.5%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: 3BK의 자본 수익률(8.1%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 12:16종가2026/05/25 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Baikowski SA는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jul 25Baikowski SA to Report First Half, 2025 Results on Sep 29, 2025Baikowski SA announced that they will report first half, 2025 results on Sep 29, 2025
Reported Earnings • Sep 25First half 2024 earnings released: EPS: €0.59 (vs €0.66 in 1H 2023)First half 2024 results: EPS: €0.59 (down from €0.66 in 1H 2023). Revenue: €26.0m (up 13% from 1H 2023). Net income: €2.17m (down 11% from 1H 2023). Profit margin: 8.3% (down from 11% in 1H 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 06Full year 2023 earnings released: EPS: €0.25 (vs €1.78 in FY 2022)Full year 2023 results: EPS: €0.25 (down from €1.78 in FY 2022). Revenue: €36.0m (down 32% from FY 2022). Net income: €938.0k (down 86% from FY 2022). Profit margin: 2.6% (down from 12% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 3% per year.
공시 • Jan 30+ 2 more updatesBaikowski SA to Report Fiscal Year 2023 Final Results on Apr 05, 2024Baikowski SA announced that they will report fiscal year 2023 final results at 8:45 AM, Central European Standard Time on Apr 05, 2024
Reported Earnings • Oct 11First half 2023 earnings released: EPS: €0.66 (vs €1.05 in 1H 2022)First half 2023 results: EPS: €0.66 (down from €1.05 in 1H 2022). Revenue: €22.9m (down 18% from 1H 2022). Net income: €2.44m (down 37% from 1H 2022). Profit margin: 11% (down from 14% in 1H 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Apr 21Full year 2022 earnings released: EPS: €1.78 (vs €1.85 in FY 2021)Full year 2022 results: EPS: €1.78 (down from €1.85 in FY 2021). Revenue: €53.0m (up 18% from FY 2021). Net income: €6.54m (down 3.5% from FY 2021). Profit margin: 12% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.
Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Claude Djololian was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • May 02Baikowski SA announces Annual dividend, payable on June 30, 2026Baikowski SA announced Annual dividend of EUR 0.3000 per share payable on June 30, 2026, ex-date on June 26, 2026 and record date on June 29, 2026.
공시 • Apr 11Baikowski SA, Annual General Meeting, Jun 11, 2026Baikowski SA, Annual General Meeting, Jun 11, 2026.
공시 • Jan 23Baikowski SA Announces Chief Executive Officer ChangesBaikowski announced a change in its executive management with the resignation of CEO Benoît Grenot, effective January 30, 2026. After more than ten years at the helm of the Group’s executive management, Benoît Grenot has decided to pursue a new professional project. The Board of Directors, chaired by François-Xavier Entremont, acknowledged Grenot's resignation. In the meantime, François-Xavier Entremont, Chairman of the Board of Directors, will assume the role of Chief Executive Officer on an interim basis and will ensure the continued implementation of the Group's development strategy.
공시 • Jul 25Baikowski SA to Report First Half, 2025 Results on Sep 29, 2025Baikowski SA announced that they will report first half, 2025 results on Sep 29, 2025
공시 • May 13Baikowski SA, Annual General Meeting, Jun 16, 2025Baikowski SA, Annual General Meeting, Jun 16, 2025. Location: 1046 route de chaumontet, poisy France
Reported Earnings • Sep 25First half 2024 earnings released: EPS: €0.59 (vs €0.66 in 1H 2023)First half 2024 results: EPS: €0.59 (down from €0.66 in 1H 2023). Revenue: €26.0m (up 13% from 1H 2023). Net income: €2.17m (down 11% from 1H 2023). Profit margin: 8.3% (down from 11% in 1H 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jul 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €15.00, the stock trades at a trailing P/E ratio of 61.4x. Average trailing P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 12% over the past three years.
New Risk • Apr 06New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.6% Last year net profit margin: 12% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.6% net profit margin). Market cap is less than US$100m (€49.2m market cap, or US$53.3m).
Reported Earnings • Apr 06Full year 2023 earnings released: EPS: €0.25 (vs €1.78 in FY 2022)Full year 2023 results: EPS: €0.25 (down from €1.78 in FY 2022). Revenue: €36.0m (down 32% from FY 2022). Net income: €938.0k (down 86% from FY 2022). Profit margin: 2.6% (down from 12% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 3% per year.
공시 • Jan 30+ 2 more updatesBaikowski SA to Report Fiscal Year 2023 Final Results on Apr 05, 2024Baikowski SA announced that they will report fiscal year 2023 final results at 8:45 AM, Central European Standard Time on Apr 05, 2024
Reported Earnings • Oct 11First half 2023 earnings released: EPS: €0.66 (vs €1.05 in 1H 2022)First half 2023 results: EPS: €0.66 (down from €1.05 in 1H 2022). Revenue: €22.9m (down 18% from 1H 2022). Net income: €2.44m (down 37% from 1H 2022). Profit margin: 11% (down from 14% in 1H 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Jun 21Upcoming dividend of €0.60 per share at 3.4% yieldEligible shareholders must have bought the stock before 28 June 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (6.1%).
Reported Earnings • Apr 21Full year 2022 earnings released: EPS: €1.78 (vs €1.85 in FY 2021)Full year 2022 results: EPS: €1.78 (down from €1.85 in FY 2021). Revenue: €53.0m (up 18% from FY 2021). Net income: €6.54m (down 3.5% from FY 2021). Profit margin: 12% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Claude Djololian was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improved over the past weekAfter last week's 17% share price gain to €29.60, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 9x in the Chemicals industry in Germany. Total returns to shareholders of 98% over the past three years.
Reported Earnings • Apr 27Full year 2021 earnings released: EPS: €1.85 (vs €0.35 in FY 2020)Full year 2021 results: EPS: €1.85 (up from €0.35 in FY 2020). Revenue: €44.9m (up 26% from FY 2020). Net income: €6.78m (up 429% from FY 2020). Profit margin: 15% (up from 3.6% in FY 2020). The increase in margin was driven by higher revenue.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Claude Djololian was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Jan 30+ 1 more updateBaikowski SA to Report First Half, 2022 Results on Sep 28, 2022Baikowski SA announced that they will report first half, 2022 results on Sep 28, 2022
공시 • Jan 28Baikowski SA, Annual General Meeting, May 20, 2022Baikowski SA, Annual General Meeting, May 20, 2022.
Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 18% share price gain to €21.40, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 102% over the past year.
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment improved over the past weekAfter last week's 51% share price gain to €20.80, the stock trades at a trailing P/E ratio of 14.6x. Average trailing P/E is 19x in the Chemicals industry in Germany. Total returns to shareholders of 120% over the past year.
Reported Earnings • Oct 03First half 2021 earnings released: EPS €0.89 (vs €0.11 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €21.7m (up 33% from 1H 2020). Net income: €3.27m (up €3.68m from 1H 2020). Profit margin: 15% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue.
Is New 90 Day High Low • Jan 19New 90-day high: €12.10The company is up 35% from its price of €8.95 on 21 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period.
Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to €12.10, the stock is trading at a trailing P/E ratio of 27.9x, up from the previous P/E ratio of 23x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total return to shareholders over the past year is a loss of 8.0%.
공시 • Jan 15+ 2 more updatesBaikowski Société anonyme to Report First Half, 2021 Results on Sep 29, 2021Baikowski Société anonyme announced that they will report first half, 2021 results on Sep 29, 2021
Valuation Update With 7 Day Price Move • Dec 23Investor sentiment improved over the past weekAfter last week's 16% share price gain to €10.70, the stock is trading at a trailing P/E ratio of 27.9x, up from the previous P/E ratio of 24x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total return to shareholders over the past year is a loss of 19%.
Is New 90 Day High Low • Dec 22New 90-day high: €10.50The company is up 9.0% from its price of €9.65 on 23 September 2020. The German market is also up 9.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 20% over the same period.
Is New 90 Day High Low • Nov 05New 90-day low: €8.10The company is down 15% from its price of €9.50 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period.
Is New 90 Day High Low • Oct 21New 90-day low: €8.95The company is down 7.0% from its price of €9.65 on 23 July 2020. The German market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period.
Reported Earnings • Oct 01First half earnings releasedOver the last 12 months the company has reported total profits of €1.59m, down 17% from the prior year. Total revenue was €38.8m over the last 12 months, largely unchanged from the prior year.